US FDA grants orphan drug designation to NMD Pharma’s NMD670 to treat patients with Charcot-Marie-tooth disease: Aarhus, Denmark Tuesday, January 7, 2025, 16:00 Hrs [IST] NMD Ph ...

The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to NMD Pharma’s oral lead development ...

NMD Pharma Announces FDA Orphan Drug Designation Granted to NMD670 for the Treatment of Patients with Charcot-Marie-Tooth Disease This is the 2nd ...

There are competing therapies to apitegromab that possess a similar mechanism of action ("MoA") to the drug, being developed by rival companies, including Roche, Biogen and NMD Pharma, Scholar ...

This page features the latest news about the Collegium Pharmaceutical stock. Collegium stock hits 52-week low at $28.46 amid market challenges In a challenging market environment, Collegium ...

In Brazil, researchers have identified substances with analgesic, anti-inflammatory, anti-hyperalgesic (against persistent pain) and anti-arthritic activity in the leaves of Annona squamosa, a ...

Karry, Global Head of Technical Marketing for BASF Pharma Solutions, on the topic of hot melt extrusion. This discussion explores how the management and analysis of vast data generated by advanced ...

NMD Pharma publishes new data on the role of ClC-1 inhibition in Charcot-Marie-Tooth in the Annals of Clinical and Translational Neurology Results from the ESTABLISH 1 observational study confirms ...

Senores Pharma IPO has reserved not less than 75% of the shares in the public issue for qualified institutional buyers (QIB), not more than 15% for non-institutional Institutional Investors (NII ...